PubRank

G Ellison

Author PubWeight™ 42.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Care of the suddenly bereaved. BMJ 1990 2.19
2 Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997 1.72
3 Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci U S A 1998 1.70
4 Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer 2009 1.50
5 Mobility impairments and use of preventive services in women with multiple sclerosis: observational study. BMJ 2001 1.38
6 Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J 2011 1.13
7 Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996 1.11
8 The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system. Br J Cancer 1998 1.09
9 Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 2001 1.08
10 Subclinical eye movement disorders in patients with multiple sclerosis. Neurology 1977 1.01
11 Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs. Pharmacol Biochem Behav 1983 0.99
12 Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus. Brain Res 2001 0.98
13 The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States. Tissue Antigens 1977 0.95
14 Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 1990 0.90
15 Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens. Synapse 1998 0.86
16 Selective neurotoxic effects of nicotine on axons in fasciculus retroflexus further support evidence that this a weak link in brain across multiple drugs of abuse. Neuropharmacology 2000 0.85
17 Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 1978 0.85
18 Animal model of psychosis: hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication. J Psychiatr Res 1981 0.83
19 Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats. J Neural Transm Gen Sect 1990 0.82
20 Enhanced stereotypies after repeated injections but not continuous amphetamines. Neuropharmacology 1978 0.82
21 Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res 1991 0.82
22 The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching. J Neuroimmunol 1988 0.82
23 Serum linoleic acid in multiple sclerosis. Neurology 1975 0.81
24 Chronic nicotine induces a specific appetite for sucrose in rats. Pharmacol Biochem Behav 1990 0.81
25 Cholinergic modulation of an opposed effect of d-amphetamine and methylphenidate on the rearing response. Psychopharmacologia 1975 0.80
26 Stages of recovery from central norepinephrine lesions in enriched and impoverished environments: a behavioral and biochemical study. Exp Brain Res 1978 0.80
27 Hyperthyroidism associated with a thyroid adenoma in a dog. J Am Vet Med Assoc 1991 0.79
28 Opposed effects of locus coeruleus and substantia nigra lesions on social behavior in rat colonies. Pharmacol Biochem Behav 1977 0.78
29 Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance? Biol Psychiatry 1980 0.78
30 Alcohol-preferring rats in colonies show withdrawal, inactivity, and lowered dominance. Pharmacol Biochem Behav 1983 0.78
31 Different effects of chronic nicotine treatment regimens on body weight and tolerance in the rat. Psychopharmacology (Berl) 1987 0.78
32 Opposed behavioral syndromes in rats with partial and more complete central serotonergic lesions made with 5,6 dihydroxytryptamine. Psychopharmacologia 1974 0.77
33 A slow-release silicone pellet for chronic amphetamine administration. Eur J Pharmacol 1977 0.77
34 A silicone pellet for continuous cocaine: comparison with continuous amphetamine. Pharmacol Biochem Behav 1991 0.77
35 Prenatal cocaine produces signs of neurodegeneration in the lateral habenula. Brain Res 1999 0.77
36 The effect of inhaled nitric oxide in pediatric asthma. Am J Respir Crit Care Med 1996 0.77
37 Delayed increases in alcohol consumption occur in rat colonies but not in isolated rats after injections of monoamine neurotoxins. Exp Neurol 1979 0.76
38 Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation. Eur J Pharmacol 1981 0.76
39 Monoamine neurotoxins: selective and delayed effects on behavior in colonies of laboratory rats. Brain Res 1976 0.76
40 Learning deficits in rats with malnourished grandmothers. Dev Psychobiol 1975 0.76
41 Opposite effects of a D1 and a D2 agonist on oral movements in rats. Eur J Pharmacol 1987 0.76
42 Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties. Psychopharmacology (Berl) 1980 0.76
43 The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism. Life Sci 1982 0.75
44 Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. J Nerv Ment Dis 1983 0.75
45 Amphetamine-induced enhancement of ethanol consumption: role of central catecholamines. Psychopharmacology (Berl) 1985 0.75
46 Tremorous mouth movements in rats administered chronic neuroleptics. Psychopharmacology (Berl) 1987 0.75
47 Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: a second opinion. Psychopharmacology (Berl) 1991 0.75
48 Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology (Berl) 1990 0.75
49 Accident and Emergency. A private disaster--bereavement. Nurs Times 1993 0.75
50 Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol 1990 0.75
51 Detection of k-ras mutations in nonsmall cell lung-carcinoma. Int J Oncol 1995 0.75
52 Exaggerated avoidance of novel stimulation in rats partially recovered from central norepinephrine damage. Pharmacol Biochem Behav 1976 0.75
53 Low-level continuous amphetamine administration selectively increases alcohol consumption. Psychopharmacology (Berl) 1982 0.75
54 The regional distribution of amphetamine in rat brain is altered by dosage and by prior exposure to the drug. J Pharmacol Exp Ther 1981 0.75
55 A silicone pellet for longterm continuous administration of amphetamine. Commun Psychopharmacol 1980 0.75
56 Long lasting changes in spontaneous and d-amphetamine elicited locomotor activity after chronic but not acute picrotoxin treatment. Proc West Pharmacol Soc 1982 0.75
57 Continuous cocaine induces persisting alterations in dopamine overflow in caudate following perfusion with a D1 agonist. J Neural Transm Gen Sect 1994 0.75
58 Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases. Analysis at the single cell level using morphological and surface marker phenotype criteria. J Neuroimmunol 1982 0.75
59 Dendritic vacuolization in the central nervous system of rats after long-term voluntary consumption of ethanol. J Neuropathol Exp Neurol 1983 0.75
60 Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors. Psychopharmacology (Berl) 1985 0.75
61 Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine. Eur J Pharmacol 1980 0.75
62 A silicone delivery system for producing binge and continuous ethanol intoxication in rats. Pharmacol Biochem Behav 1981 0.75
63 Alterations in the stages of continuous amphetamine intoxication produced by lesions of locus coeruleus and substantia nigra. Gen Pharmacol 1982 0.75
64 Long-lasting alterations in behavior and brain neurochemistry following continuous low-level LSD administration. Pharmacol Biochem Behav 1989 0.75
65 Tricyclic antidepressants: effects on extinction and fear learning. Pharmacol Biochem Behav 1975 0.75
66 The aging psychiatric hospital: an approach to humanistic redesign. Hosp Community Psychiatry 1976 0.75
67 Phasic alterations in dopamine metabolites following continuous administration of amphetamine. Brain Res 1983 0.75
68 A refillable system for continuous amphetamine administration: effects upon social behavior in rat colonies. Commun Psychopharmacol 1978 0.75
69 Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs. Pharmacol Biochem Behav 1989 0.75
70 The regional distribution of d-amphetamine and local glucose utilization in rat brain during continuous amphetamine administration. Exp Brain Res 1981 0.75
71 Drug holidays alter onset of oral movements in rats following chronic haloperidol. Biol Psychiatry 1984 0.75
72 Through the darkest hour. Community Outlook 1990 0.75
73 Rib biopsy technique for cortical bone evaluation in rhesus monkeys (Macaca mulatta). Lab Anim Sci 1999 0.75
74 Stages of constant amphetamine intoxication: delayed appearance of abnormal social behaviors in rat colonies. Psychopharmacology (Berl) 1978 0.75